Motilal Oswal
ZENT reported a decent 3QFY25, with revenue growth of 0.7% QoQ CC (est. flat growth), driven by Manufacturing & Consumer services (up 6.5% QoQ CC) and Healthcare & Lifesciences (up 3.2% QoQ CC).
Zensar Technologies Ltd. is trading below all available SMAs
More from Zensar Technologies Ltd.
Recommended